Technical Analysis for ACST - Acasti Pharma, Inc.

Grade Last Price % Change $ Change
grade F $1.23 -3.91% -0.05
ACST closed down 3.91 percent on Thursday, February 23, 2017, on 40 percent of normal volume. It ran into resistance at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical ACST trend table...

Date Alert Name Type % Chg
Feb 23 50 DMA Resistance Bearish 0.00%
Feb 23 Stochastic Reached Oversold Other 0.00%
Feb 23 Bollinger Band Squeeze Range Contraction 0.00%
Feb 22 50 DMA Resistance Bearish -3.91%
Feb 22 Bollinger Band Squeeze Range Contraction -3.91%
Feb 22 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -3.91%
Feb 21 Fell Below 50 DMA Bearish -3.91%
Feb 21 200 DMA Resistance Bearish -3.91%
Feb 21 Shooting Star Candlestick Bearish -3.91%
Feb 21 Lizard Bearish Bearish Day Trade Setup -3.91%

Older signals for ACST ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.

Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of new therapies for abnormalities in blood lipids, and the treatment and prevention of cardiovascular disorders. The company offers Onemia, a medical food that is used in the dietary management of illnesses associated with omega-3 phospholipids deficiency related to cardiometabolic disorders. Its product development pipeline includes CaPre, a drug product candidate that is in Phase II clinical trial for the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia. The company was incorporated in 2002 and is headquartered in Laval, Canada. Acasti Pharma Inc. is a subsidiary of Neptune Technologies & Bioressources Inc.
Is ACST a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 3 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 3.09
52 Week Low 1.11
Average Volume 248,496
200-Day Moving Average 1.43
50-Day Moving Average 1.29
20-Day Moving Average 1.29
10-Day Moving Average 1.28
Average True Range 0.11
ADX 49.7
+DI 33.82
-DI: 11.76
Chandelier Exit (Long, 3 ATRs) 1.27
Chandelier Exit (Short, 3 ATRs) 1.55
Upper Bollinger Band 1.34
Lower Bollinger Band 1.24
Percent B (%b) -0.1
Bandwidth 0.077519